Rocket Doctor AI Inc. Grants RSUs and Stock Options
Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) has announced the grant of an impressive total of 831,356 restricted share units ("RSUs") and 20,964 stock options to various consultants and employees linked to the Company and its subsidiary, Rocket Doctor Inc.
Details of the Stock Options and RSUs
Each stock option is set at an exercise price of C$0.82, allowing for the acquisition of one common share for a duration of three years post-grant, contingent upon vesting requirements. Among the RSUs granted, 325,000 will be valid for a two-year period, while 506,356 will remain valid for three years. Notably, 203,000 RSUs are set for immediate vesting, with the remaining 628,356 subject to specific vesting provisions. All granted options and RSUs are governed by the Company’s equity plans and the requisite securities laws.
About Rocket Doctor AI Inc.
Rocket Doctor AI Inc. aims to transform the healthcare landscape with physician-driven, AI-enhanced solutions that ensure quality healthcare is accessible throughout the patient's journey. Central to this mission is the Global Library of Medicine (GLM), a clinically validated decision support system formulated with the insights of numerous physicians around the globe.
Innovative Healthcare Solutions
Supporting Rocket Doctor AI is its subsidiary, Rocket Doctor Inc., which features an AI-powered digital health platform and marketplace. This innovative approach has already empowered over 300 medical doctors (MDs) to deliver care to over 700,000 patient visits. Their proprietary technology not only enables doctors to efficiently initiate and manage their own virtual or hybrid in-person practices, but it also enhances healthcare delivery overall.
Focus on Community Health
The ethos of Rocket Doctor AI focuses on alleviating the administrative burdens that often plague healthcare workers, allowing for meaningful interactions between physicians and patients. Their dedicated efforts ensure support reaches underserved communities, especially in rural and remote areas in Canada that frequently struggle with access to family medicine. Furthermore, the technology aims to assist patients relying on Medicaid and Medicare in the United States.
Expanding Reach and Capabilities
By leveraging advanced AI technologies, large language models, and connected medical devices, Rocket Doctor AI is not only redefining access to healthcare, but it is also striving to create a more equitable, scalable, and patient-centered system. This strategy underscores their commitment to enhancing the healthcare experience for both providers and patients alike.
Contact Information
For further details on Rocket Doctor AI Inc.’s solutions and services, interested parties can reach out via their website or email. You can visit www.rocketdoctor.ai or email at info@rocketdoctor.ai. For direct inquiries, individuals can contact:
Dr. Essam Hamza, CEO, Rocket Doctor AI
essam.hamza@rocketdoctor.ai
Dr. Bill Cherniak, CEO, Rocket Doctor Inc.
bill@rocketdoctor.io
Media inquiries can be directed to media@rocketdoctor.ai or by calling +1 (778) 819 8321.
Frequently Asked Questions
What are RSUs and stock options?
RSUs or restricted share units are stocks granted to employees as part of their compensation. Stock options give employees the right to purchase shares at a predetermined price.
How long are the stock options valid?
The stock options issued by Rocket Doctor AI are valid for three years from the grant date.
Who benefits from these RSUs and stock options?
Consultants and employees of Rocket Doctor AI and its subsidiary stand to gain from the granted RSUs and stock options, encouraging their continued commitment to the company.
What is the exercise price for the stock options?
The exercise price for the stock options is set at C$0.82 per share.
What is the mission of Rocket Doctor AI Inc.?
Rocket Doctor AI Inc. aims to create AI-powered healthcare solutions that facilitate accessible and high-quality care throughout the patient's healthcare journey.
